SOPHiA GENETICS (SOPH) Consolidated Net Income (2020 - 2025)

SOPHiA GENETICS (SOPH) has 6 years of Consolidated Net Income data on file, last reported at -$20.0 million in Q4 2025.

• For the quarter ending Q4 2025, Consolidated Net Income fell 43.39% year-over-year to -$20.0 million; the trailing twelve-month figure through Dec 2025 stood at -$76.0 million (down 26.53% YoY), and the FY2025 full-year result was -$76.0 million, down 26.53% from the prior year.
• Consolidated Net Income fell to -$20.0 million in Q4 2025, from -$18.7 million in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of -$12.5 million in Q1 2021 to a low of -$498.3 million in Q3 2021.
• A 5-year average of -$44.6 million and a median of -$19.7 million in 2023 frame the typical range for Consolidated Net Income.
• Peak annual rise in Consolidated Net Income reached 99.26% in 2021, while the deepest fall reached 211.91% in 2021.
• Tracing SOPH's Consolidated Net Income over 5 years: stood at -$21.9 million in 2021, then soared by 35.03% to -$14.2 million in 2022, then sank by 69.16% to -$24.1 million in 2023, then surged by 42.14% to -$13.9 million in 2024, then sank by 43.39% to -$20.0 million in 2025.
• Business Quant data shows SOPH's Consolidated Net Income at -$20.0 million in Q4 2025, -$18.7 million in Q3 2025, and -$20.9 million in Q2 2025.